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ABSTRACT Rab11a is a key modulator of vesicular trafficking processes, but there is limited 
information about the guanine nucleotide-exchange factors and GTPase-activating proteins 
(GAPs) that regulate its GTP-GDP cycle. We observed that in the presence of Mg2+ (2.5 mM), 
TBC1D9B interacted via its Tre2-Bub2-Cdc16 (TBC) domain with Rab11a, Rab11b, and Rab4a 
in a nucleotide-dependent manner. However, only Rab11a was a substrate for TBC1D9B-
stimulated GTP hydrolysis. At limiting Mg2+ concentrations (<0.5 mM), Rab8a was an addi-
tional substrate for this GAP. In polarized Madin–Darby canine kidney cells, endogenous TB-
C1D9B colocalized with Rab11a-positive recycling endosomes but less so with EEA1-positive 
early endosomes, transferrin-positive recycling endosomes, or late endosomes. Overexpres-
sion of TBC1D9B, but not an inactive mutant, decreased the rate of basolateral-to-apical IgA 
transcytosis—a Rab11a-dependent pathway—and shRNA-mediated depletion of TBC1D9B 
increased the rate of this process. In contrast, TBC1D9B had no effect on two Rab11a-inde-
pendent pathways—basolateral recycling of the transferrin receptor or degradation of the 
epidermal growth factor receptor. Finally, expression of TBC1D9B decreased the amount of 
active Rab11a in the cell and concomitantly disrupted the interaction between Rab11a and 
its effector, Sec15A. We conclude that TBC1D9B is a Rab11a GAP that regulates basolateral-
to-apical transcytosis in polarized MDCK cells.
INTRODUCTION
Collectively Rab GTPases form a large family of evolutionarily con-
served proteins (42 subfamilies in humans) that coordinate vesicle 
fission, transport, tethering, and fusion (Stenmark, 2009). Their 
function is regulated by specific guanine nucleotide-exchange fac-
tors (GEFs), GTPase-activating proteins (GAPs), and GDP dissociation 
inhibitors. Whereas GEFs activate their cognate Rabs by promoting 
the exchange of GDP for GTP, GAPs facilitate the hydrolysis of GTP 
to GDP, returning Rabs to their inactive, GDP-bound state. Studies 
in the past few years have identified a family of Tre2-Bub2-Cdc16 
(TBC) domain–containing proteins, several members of which have 
Rab GAP activity. This function depends on two conserved motifs in 
their TBC domain: an arginine or R finger within an IxxDxxR motif, 
and a glutamine or Q finger within an YxQ motif. Whereas the con-
served Y residue in the Q finger interacts with the conserved switch 
II glutamate residue of the Rab GTPase, the R and Q residues of 
TBC proteins coordinate the Rab-bound GTP, promoting its hydro-
lysis (Pan et al., 2006; Gavriljuk et al., 2012). The Rab specificity and 
GAP activity have been defined for some TBC-domain proteins 
(Fukuda, 2011; Frasa et al., 2012), but there is limited information for 
the other family members, including TBC1D9B.
Structurally, TBC1D9B is composed of two N-terminal GRAM 
domains, a central TBC domain (which includes R and Q fingers), 
and a C-terminal EF hand motif (Doerks et al., 2000; Frasa et al., 
2012). The closest nonvertebrate orthologue to TBC1D9B is the 
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where short hairpin RNA (shRNA)–mediated depletion of TBC1D9B 
increased the rate of this process. Furthermore, expression of TB-
C1D9B decreased the amount of active Rab11a in the cell and con-
comitantly disrupted the interaction between Rab11a and its effec-
tor, Sec15A. We discuss the likelihood that TBC1D9B acts as a 
Rab11a GAP in polarized MDCK cells, where it regulates the Rab11a-
dependent IgA-pIgR transcytotic pathway. We also discuss the pos-
sibility that TBC1D9B may act as an effector of Rab11b and/or 
Rab4a.
RESULTS
TBC1D9B interacts with specific Rab GTPases
TBC1D9B is an ∼140-kDa TBC domain–containing protein with a 
comparable domain architecture to Gyp2p (Figure 1A). Further-
more, the overall similarity of these proteins is reasonably high at 
49% and increases to 64% when the TBC domains are assessed in-
dividually. The TBC domain of TBC1D9B contains conserved R, Y, 
and Q residues, which form the “R” and “Q” fingers that are critical 
for GTP hydrolysis in other TBC proteins (Figure 1B; Pan et al., 2006; 
Gavriljuk et al., 2012).
To identify possible substrates for TBC1D9B, we first tested 
whether TBC1D9B could bind to Rab GTPases—Rab11a in particu-
lar—using a yeast two-hybrid assay with TBC1D9B as bait and differ-
ent Rabs as prey (Supplemental Figure S1). A positive interaction 
was found between TBC1D9B and Rab11aQ70L (abbreviated 
Rab11a-QL), a mutant of Rab11a that was proposed to be defective 
in GTP hydrolysis (Adari et al., 1988; Stenmark et al., 1994; Ullrich 
et al., 1996). Notwithstanding a previous report that this mutant is 
able to hydrolyze GTP and therefore may not be constitutively 
yeast protein Gyp2p, which has a similar domain architecture (but 
has only one GRAM domain) and apparently acts as a GAP for 
Ypt31p, a homologue of Rab11a (Sciorra et al., 2005). No studies 
have defined whether vertebrate TBC1D9B has GAP activity or 
have determined its Rab specificity.
Rab11a is a well-studied Rab GTPase that regulates exocytosis 
and is critical for a variety of cellular processes, including membrane 
protein recycling (Ullrich et al., 1996; Wang et al., 2000b), transcyto-
sis (Wang et al., 2000b; Su et al., 2010; Xu et al., 2011), regulated 
exocytosis (Khandelwal et al., 2008, 2013), cytokinesis (Fielding 
et al., 2005; Wilson et al., 2005; Yu et al., 2007), ciliogenesis (Knodler 
et al., 2010; Westlake et al., 2011), lumenogenesis (Desclozeaux 
et al., 2008; Bryant et al., 2010), and autophagosome formation 
(Fader et al., 2008; Longatti et al., 2012). Whereas many studies 
have focused on identifying Rab11a effectors (e.g., FIP1-5 and 
Sec15A; Hales et al., 2001; Lindsay et al., 2002; Wallace et al., 2002; 
Zhang et al., 2004; Wu et al., 2005; Oztan et al., 2007; Horgan and 
McCaffrey, 2009; Baetz and Goldenring, 2013), much less is known 
about the specific GEFs and GAPs that regulate vertebrate Rab11a 
activity, and the majority of insights have come from studies in model 
organisms. In yeast, the multisubunit TRAPII complex is reported to 
act as a GEF for Ypt31p and Ypt32p (Jones et al., 2000; Morozova 
et al., 2006), which is an additional orthologue of Rab11a. However, 
the purified TRAPII complexes may lack GEF activity in mammalian 
cells (Yamasaki et al., 2009). In addition, the Drosophila protein Crag 
acts as a GEF for Rab11 in photoreceptor cells (Xiong et al., 2012) 
and for Rab10 in in vitro studies (Yoshimura et al., 2010). In the case 
of GAPs, the TBC-domain-containing protein Evi5 regulates border 
cell migration during Drosophila oocyte development by acting as a 
Rab11a GAP (Laflamme et al., 2012). How-
ever, whether Evi5 acts as a GAP for verte-
brate Rab11a is controversial. Some reports 
indicate that it lacks Rab11a GAP activity, 
whereas others point to the opposite con-
clusion (Dabbeekeh et al., 2007; Fuchs et al., 
2007; Westlake et al., 2007; Hehnly et al., 
2012). Another TBC-containing protein, 
TBC1D14, appears to bind to Rab11a and 
Rab11b and regulate autophagosome for-
mation but apparently does not function as 
a GAP but does function as a Rab11a/b ef-
fector (Longatti et al., 2012). Thus, the regu-
latory proteins that regulate the vertebrate 
Rab11a GTPase cycle remain to be defined 
and characterized.
Using a polarized Madin–Darby canine 
kidney (MDCK) cell culture model, coupled 
with in vitro assays, we observed the follow-
ing. Although able to interact with Rab11a, 
Rab11b, and Rab4a in a nucleotide depen-
dent manner, TBC1D9B only stimulated 
Rab11a GTP hydrolysis in vitro. Further-
more, endogenous TBC1D9B colocalized 
with Rab11a-dependent endosomes, as 
well as with cargoes that transit these endo-
somes, including immunoglobulin A (IgA) 
bound to the polymeric immunoglobulin re-
ceptor (pIgR), the archetypal basolateral-to-
apical transcytotic protein. We further ob-
served that overexpression of TBC1D9B, 
but not an inactive mutant, slowed the rate 
of basolateral-to-apical IgA transcytosis, 
FIGURE 1: Domain structure of TBC1D9B and sequence comparisons of its TBC domain with 
other TBC domain–containing proteins. (A) Schematic of human TBC1D9B and Saccharomyces 
cerevisiae Gyp2p domain structure. Predicted GRAM domains are colored pink, TBC domains 
are colored green, and EF hands are colored light blue. (B) Alignment of the indicated region of 
the TBC domains using MAFFT software (Larkin et al., 2007; Katoh and Standley, 2013). 
Sequences including the arginine (R) and glutamine (Q) fingers are shaded gray; key amino acids 
in the R and Q fingers are shaded red. Identical residues are indicated with an asterisk, 
conserved amino acid substitutions by a colon, and semiconserved substitutions by a period. 
The percentage of identity (Id) or similarity (Sim) between the TBC domain of TBC1D9B and 
those of the indicated proteins is given in the right-hand columns.
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structure of the TBC1D4 TBC domain as a 
template (Protein Data Bank [PDB] file 
3QYB; Park et al., 2011). Figure 3A shows 
the predicted structure of the TBC domain 
of TBC1D9B superimposed on the known 
structure of the TBC1D4 TBC domain. The 
structural overlap parameter obtained was 
64%, confirming that the two structures 
were structurally related (Geourjon et al., 
2001). In addition, the putative catalytic resi-
dues (R559, Y592, and Q594) of TBC1D9B were 
exposed similarly to those of TBC1D4 and 
other TBC proteins such as Gyp1p (unpub-
lished data). Thus, the sequence homolo-
gies and predicted structure are consistent 
with the possibility that TBC1D9B was a 
functional GAP.
Next, we evaluated whether TBC1D9B 
had measurable GAP activity. Because we 
were unable to express sufficient quantities 
of the full-length protein in Escherichia 
coli (TBC1D9B has a molecular weight of 
∼140 kDa), we synthesized fragments of TB-
C1D9B and tested these for GAP activity 
(Supplemental Figure S2A). The fragment 
301–810, which we refer to as TB-
C1D9B-(301-810), retained maximal in vitro 
GAP activity against Rab11a and was used in 
our subsequent studies (Supplemental 
Figure S2B). Of the 14 Rabs tested, a signifi-
cant increase in mean GAP activity was ob-
served only in the case of Rab8a and Rab11a (Figure 3B). However, 
no GAP activity was detected for the other Rabs, including Rab4a, or 
the other Rab11 family members Rab11b and Rab25. Further analysis 
revealed a linear dependence between the TBC1D9B-(301-810) con-
centration and the initial rate of Rab11a-GTP hydrolysis (Figure 3, C 
and D). At 4 μM, the extent of GTP hydrolysis was 9.7 times greater 
than GTP hydrolysis in the absence of TBC1D9B-(301-810) (Figure 
3C), and the calculated rate of GTP hydrolysis was 4.8 times that of 
the intrinsic rate of Rab11a GTPase activity in the absence of 
TBC1D9B-(301-810) (Figure 3D). The catalytic efficiency of wild-type 
TBC domain was calculated as 158.3 M−1 s−1.
As a control for these studies, we generated variants of TBC1D9B 
that contained mutations in key amino acids exposed in the active 
site of the protein (Figures 1B and 3A) and were therefore likely to 
lack activity. To screen for inactive TBC1D9B mutants, we used non-
polarized HEK cells. In these cells, we observed a significant redistri-
bution of Rab11a from recycling endosomes (which appear as a 
juxtanuclear cluster in these images) to the cytosol when TBC1D9B 
was overexpressed (Supplemental Figure S3A). However, this redis-
tribution was not observed in cells expressing TBC1D9B-Y592A/
Q594A (abbreviated YQ/AA) or TBC1D9B-R559A/Y592A/Q594A 
(abbreviated RYQ/AAA) (Supplemental Figure S3, A and B). In con-
trast, expression of TBC1D9B-RA did not differ in effect from the 
wild-type TBC1D9B. This may indicate that this mutant retains some 
or all of its GAP activity, as opposed to the previously described loss 
of activity caused by equivalent mutations in the Gyp1p and Gyp7p 
yeast GAPs (Albert et al., 1999). As a control for these experiments, 
we observed that wild-type or mutant variants of TBC1D9B had no 
effect on the distribution of Rab33b (Supplemental Figure S3, A and 
C), which we showed is not an apparent substrate for TBC1D9B 
(Figure 3B). As further confirmation that TBC1D9B-RYQ/AAA is an 
active (Casanova et al., 1999), a more recent study demonstrates 
that Rabs with Q-to-L mutations retain the ability to hydrolyze GTP, 
albeit at a reduced level to the wild-type protein (Gavriljuk et al., 
2012). No interaction was observed when a GDP-locked mutant of 
Rab11a was used (Rab11aS25N; abbreviated Rab11a-SN) or when 
other Rab GTPases (Rab5, Rab6, Rab7, Rab33, and Rab4), nominally 
in their GTP-locked or GDP-locked configuration, were tested. Haas 
et al. (2005) previously described that an inactivating mutation in the 
R finger of the TBC domain can enhance the interaction between a 
TBC domain–containing protein and its substrate. When we mu-
tated Arg-559 in TBC1D9B to an Ala residue (R559A; abbreviated 
TBC1D9B-RA), we observed that the interaction with Rab11a-QL 
was stronger (Supplemental Figure S1). However, under these con-
ditions, we also observed interactions with Rab11a-SN and to a 
lesser extent with Rab4 and the empty pB42AD prey vector.
As an additional method to screen for TBC1D9B interactions, we 
determined whether flag-TBC1D9B could coimmunoprecipitate a 
broader array of GFP-tagged, GTP-locked mutants of Rab proteins 
previously implicated in endocytic and exocytic membrane traffic. 
Of the Rabs tested, we observed that Rab11a-QL, Rab11b-QL, and 
Rab4a-QL formed significant interactions with flag-TBC1D9B 
(Figure 2). In contrast, little interaction was observed with nominally 
GTP-locked mutants of Rab3a, Rab5a, Rab6a, Rab7, Rab8a, Rab10, 
Rab13, Rab25, Rab27a, or Rab33a (Figure 2). Taken together, these 
results indicate that TBC1D9B forms interactions with a selective 
number of Rab GTPases, including Rab11a, Rab11b, and Rab4a.
TBC1D9B stimulates Rab11a GTP hydrolysis
We next sought to determine whether TBC1D9B had GAP activity 
against any of its binding partners. We first performed comparative 
protein structure modeling using the known three-dimensional (3D) 
FIGURE 2: TBC1D9B interacts with Rab GTPases. (A) Flag-tagged TBC1D9B, along with the 
indicated GFP-Rabs containing an activating Q-to-L mutation, were coexpressed in HEK cells. 
Flag-TBC1D9B was recovered using an anti-flag tag antibody and coimmunopreciptated 
GFP-tagged Rab-QL detected using an anti-GFP antibody. IgG was used as a nonspecific 
control. (B) Quantification of the percentage GFP-Rab-QL coimmunoprecipitated with TBC1D9B 
normalized to the total amount of GFP-Rab-QL in the lysate. Data were obtained from three 
independent experiments, and the mean ± SEM is shown. Values significantly different from the 
group means, assessed by ANOVA, are indicated (*p < 0.05).
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FIGURE 3: TBC1D9B in vitro GAP activity. (A) TBC1D4 (PDB: 3QYB) was used as a template (gray) to model the 3D 
structure of the TBC1D9B TBC domain (green). (B) GTP hydrolysis by the indicated wild-type, GST-tagged Rab loaded 
with [γ-32P]GTP and incubated with 2 μM of either wild-type or mutant TBC1D9B-(301-810) for 60 min at 30°C. Data are 
corrected for reactions lacking the TBC1D9B fragment. Those values significantly different from the group means, 
assessed by ANOVA, are indicated (*p < 0.05). (C) Kinetics of Rab11a GTP hydrolysis loaded with [γ-32P]GTP and 
incubated with 0, 0.5, 1, 2, or 4 μM recombinant TBC1D9B-(301-810). (D) Initial rates of Rab11a GTP hydrolysis plotted 
against the concentration of wild-type or mutant TBC1D9B-(301-810). (E) In vitro GAP assays performed in the presence 
of Rab11a or Rab8a. In these reactions, Mg2+ mixed at a 1:1 M ratio with GTP, was added at a final concentration of 
0.5 mM. Alternatively, the reaction was supplemented with 5 mM MgCl2. Reactions were incubated for 30 min at 30°C. 
Data were normalized to control reactions in which no TBC1D9B-(301-810) was added. Values for TBC1D9B-(301-810) 
that were significantly different (p < 0.05) from matched incubations performed in the presence of TBC1D9B-RYQ/AAA 
(301-810) or between the indicated reactions are identified with an asterisk. (F) Top, full-length flag-TBC1D9B-WT or 
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(Figure 4D). Fragments lacking the TBC domain did not interact with 
GFP-Rab11a (Figure 4D, left), whereas all fragments containing the 
TBC domain, including those with flanking N-and C-terminal amino 
acids, interacted with Rab11a (Figure 4D, right). As expected, the 
TBC1D9B-(301-810)-RYQ/AAA mutant retained the ability to inter-
act with Rab11a (Figure 4D, lane #2RYQ). Finally, we observed that, 
like the full-length protein, flag-TBC1D9B-(301-810) showed the 
greatest interaction with Rab11a-QL and less with Rab11a-WT or 
Rab11a-SN (Figure 4, E–G).
The foregoing results demonstrate that Rab11a interacts with 
TBC1D9B via its TBC domain and that this interaction is dependent 
on the nucleotide state of Rab11a. We further observe that mutants 
that alter the TBC active site show increased binding to Rab11a.
TBC1D9B interacts with Rab11b and Rab4a in a 
nucleotide-dependent manner
Next, we further explored the interaction of TBC1D9B with Rab11b 
and Rab4a. Although not substrates for TBC1D9B (Figure 3B), both 
Rabs were found to coimmunoprecipitate with flag-TBC1D9B ex-
pressed in HEK cells (Figure 2). Of interest, when wild-type (WT), 
GTP-locked (QL), and GDP-locked (SN) mutants of Rab11b were 
compared in an immunoprecipitation assay (Figure 5A), we ob-
served that flag-TBC1D9B interacted most efficiently with Rab11b-
QL. In a somewhat similar manner, both the WT and QL forms, but 
not the SN mutant, of Rab4a also interacted with TBC1D9B (Figure 
5B). However, we did note that TBC1D9B interacted more strongly 
with Rab4a-WT than Rab4a-QL. Whereas full-length flag-TBC1D9B 
showed the rank efficiency for interactions with its cognate Rabs as 
Rab11b > Rab11a > Rab4a (Figure 2), the efficiency of interaction for 
the GST-TBC1D9B-(301-810) fusion protein was Rab11b > Rab4a > 
Rab11a (Figure 5, E, F, and H). Thus, there were some differences in 
the interactions between the full-length protein and the 301–810 
protein fragment. We also studied the interaction between TB-
C1D9B and Rab8a, which was observed when the Mg2+ in the buffer 
was removed. Under these conditions, there was little difference in 
the binding efficiency between flag-TBC1D9B and Rab8a-QL and 
Rab11a-QL (Figure 5C). However, when the assay was supplemented 
with 2.5 mM Mg2+, neither Rab8a-WT nor Rab8a-QL interacted with 
flag-TBC1D9B (Figure 5D). Oddly, in the presence of Mg2+, Rab8a-
SN showed a strong interaction with flag-TBC1D9B.
These results demonstrate that in the presence of 2.5 mM Mg2+, 
TBC1D9B selectively interacts with GTP-locked mutants of Rab4a and 
Rab11b but not with GDP-locked variants or with Rab8a-WT/-QL.
TBC1D9B localizes to Rab11a-positive endosomes
To better understand the site of TBC1D9B function in the cell, we 
studied its subcellular localization in polarized epithelial MDCK cells. 
In these cells, endogenous TBC1D9B was vesicular in appearance 
and accumulated in the apical cytoplasm of the cell up to the level 
of the apical membrane (defined by GP-135 or actin staining in 
Figure 6A). TBC1D9B did not localize to EEA1-positive early endo-
somes or to LAMP2-labeled late endosomes/lysosomes (Figure 6, 
B–D; Manders coefficient of colocalization of 0.031 ± 0.005 
and 0.035 ± 0.005, respectively). TBC1D9B also partially localized 
with the giantin-labeled Golgi (coefficient of colocalization of 
inactive mutant, we showed that it lacked significant GAP activity in 
the in vitro assays described earlier (Figure 3, B–D).
We were initially surprised that Rab8a-QL served as a substrate 
for TBC1D9B in the GAP assays (Figure 3B) but did not coimmuno-
precipitate with flag-TBC1D9B (Figure 2). Additional experimentation 
revealed that these differences were likely related to the amount of 
Mg2+ used in these assays. Whereas the in vitro GAP assays were 
initially performed in minimal concentrations of Mg2+ (GTP bound 
with Mg2+ was used in the assays at a final concentration of 0.5 mM), 
similar to previous reports (Krugmann et al., 2004; Haas et al., 2005; 
Fuchs et al., 2007; Yoshimura et al., 2008), the coimmunoprecipita-
tion studies in Figure 2 were performed in the presence of an addi-
tional 2.5 mM Mg2+ (Oztan et al., 2007; Tsun et al., 2013). Of inter-
est, when we removed Mg2+ from the coimmunoprecipitation 
studies, we observed interactions between GFP-Rab8a-QL and flag-
TBC1D9B (see later discussion of Figure 5C). In contrast, supple-
menting the concentration of Mg2+ in the GAP assays by 5 mM 
MgCl2 (Du et al., 1998; Albert et al., 1999; Casanova et al., 1999) 
evoked a significant increase in Rab11a GTPase activity (Figure 3E) 
but not for Rab8a (Figure 3E) or any of the other Rab GTPases tested 
(Supplemental Figure S2C). Finally, we expressed full-length flag-
TBC1D9B in HeLa cells and then recovered the protein by immuno-
precipitation. Like TBC1D9B-(301-810), the full-length protein 
showed GTPase activity only against Rab11a and not Rab8a 
(Figure 3F).
In summary, these results demonstrate that when the assay reac-
tions are supplemented with 5.0 mM Mg2+, TBC1D9B shows great-
est activity toward Rab11a.
Rab11a binds to the TBC domain of TBC1D9B
Next, we explored the nature of the interaction between TBC1D9B 
and Rab11a. In general, GAPs are believed to interact most robustly 
to Rabs in their GTP-bound state and less so with Rabs in their GDP-
bound state (Will and Gallwitz, 2001; Haas et al., 2005; Fuchs et al., 
2007; Hannemann et al., 2012). Consistent with this finding, we ob-
served that immunoisolated flag-tagged TBC1D9B coimmunopre-
cipitated approximately five times more avidly with Rab11a-QL than 
with Rab11a-WT or Rab11a-SN (Figure 4A). Mutations of the R and/
or Q fingers in the TBC domain are reported to alter TBC–protein 
interaction with Rab-GTP, either enhancing it (Will and Gallwitz, 
2001; Haas et al., 2005; Itoh et al., 2006) or impairing it (Itoh et al., 
2006). In the case of TBC1D9B, we observed that full-length flag-
TBC1D9B-RYQ/AAA coimmunoprecipitated Rab11a-WT in a man-
ner that was greater than for the wild-type flag-TCB1D9B protein 
(Figure 4B). Thus, our results were similar to those reported for 
RUTBC-3/RabGAP-5, USP6NL/RN-Tre, and Gyp6p, all of which 
show increased binding to variants of their cognate TBC GAPs that 
contain mutations in their active-site residues (Will and Gallwitz, 
2001; Haas et al., 2005).
The foregoing results indicate that R559, Y592, and Q594 are unlikely 
to mediate the binding between TBC1D9B and Rab11a. To assess 
which domain(s) of TBC1D9B were responsible for binding Rab11a, 
we generated glutathione S-transferase (GST)–tagged fragments of 
TBC1D9B containing or lacking the TBC domain (Figure 4C). These 
were used to pull down GFP-Rab11a-WT produced in HEK cells 
flag-TBC1D9B-RYQ/AAA was immunoprecipitated from HeLa cell lysates and a GAP assay performed using Rab11a or 
Rab8a loaded with [γ-32P]GTP and incubated for 60 min at 30°C. Lysates from nontransfected cells were used as 
controls. Bottom, Western blot of a 5-μl aliquot of the immunoprecipitates used in the in vitro assay was detected using 
an anti-flag antibody. (B–F) Data were obtained from three or more independent experiments performed in duplicate, 
and the mean ± SEM is shown. In E and F, values significantly different between TBC1D9B-WT and TBC1D9B-RYQ/AAA 
are indicated with an asterisk (p < 0.05).
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FIGURE 4: Rab11a binds to the TBC domain of TBC1D9B. (A) Left, coimmunoprecipitation of flag-tagged TBC1D9B 
with GFP-Rab11a-wild-type (WT), GTP-locked GFP-Rab11aQ70L (QL), or GDP-locked GFP-Rab11aS25N (SN) 
coexpressed in HEK cells. Anti-flag antibody was used to recover flag-TBC1D9B, and coimmunopreciptated GFP-
Rab11a was detected using an anti-GFP antibody. Controls included use of IgG instead of the flag-tag antibody and 
expression of GFP-Rab11a alone (first lane). Right, 2% of each lysate was resolved by SDS–PAGE and the indicated 
proteins detected by Western blot. Bottom, quantification of coimmunoprecipitations. Values were normalized to the 
total expression of each protein first and then to the values obtained in experiments using the Rab11a-WT lysate.  
(B) HEK cells were cotransfected with GFP-Rab11a and either flag-TBC1D9B-wild-type (WT) or the flag-TBC1D9B-RYQ/
AAA mutant (RYQ). Flag-tagged TBC1D9B was recovered by immunoprecipitation, and the amount of GFP-Rab11a was 
quantified. Control reactions were performed for cells that only expressed GFP-Rab11a, or in some cases IgG was 
substituted for the anti-flag antibody. Right, 2% of each lysate was resolved by SDS–PAGE and the indicated proteins 
detected by Western blot. Bottom, amount of coimmunoprecipitated GFP-Rab11a normalized to the amount recovered 
from the TBC1D9B-WT lysate. (C) Fragments of TBC1D9B used in pull-down studies. (D) Top, GST-TBC1D9B fragments, 
labeled according to C, were used to affinity capture GFP-Rab11a in HEK cell lysates. Here #2RYQ denotes the use of 
fragment #2 with the RYQ/AAA mutations. GST alone was used as a control. Bottom, GST constructs were resolved by 
SDS–PAGE and proteins blotted with anti-GST antibody. (E, F) Top left, GST-TBC1D9B-#2 fragment was used to affinity 
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somes to the cytosol when TBC1D9B-WT, but not when the inactive 
mutant TBC1D9B-RYQ/AAA, was expressed (Supplemental Figure 
S2, A and B). This is the expected result for HEK cells if the 
GDP-bound form of Rab11a increased as a result of expressing TB-
C1D9B-WT. Finally, when Rab11a expression was depleted using a 
specific shRNA, endogenous TBC1D9B’s normal accumulation in 
the apical half of the cell was altered, and its distribution became 
more dispersed throughout the cell (Supplemental Figure S5D).
Taken together, these results indicate that TBC1D9B is associ-
ated with endocytic vesicles, including those likely to contain active 
Rab11a. Moreover, the loss of Rab11a expression results in an al-
tered distribution of TBC1D9B, further pointing to an interaction 
between these proteins.
TBC1D9B regulates basolateral-to-apical transcytosis but not 
transferrin recycling or epidermal growth factor degradation
If TBC1D9B acts as a Rab11a-GAP, we reasoned that increasing its 
expression should down-regulate Rab11a activity and in doing so 
alter Rab11a-dependent trafficking events. We first tested the ef-
fects of TBC1D9B expression on the efficiency of basolateral-to-
apical IgA transcytosis, a known Rab11a-dependent trafficking event 
(Casanova et al., 1999; Wang et al., 2000b). As expected, expression 
of TBC1D9B-WT, but not TBC1D9B-RYQ/AAA, significantly slowed 
the rate of IgA transcytosis, particularly at early time points (Figure 
8A). We also tested the effects of TBC1D9B-WT expression on the 
fraction of IgA that recycles apically, a trafficking event that shows 
partial dependence on Rab11a (Wang et al., 2000b). Although the 
effect was not pronounced, there was a small but significant inhibi-
tion in the amount of IgA that recycled apically (Figure 8B). We also 
tested two pathways known to be Rab11a independent, including 
basolateral recycling of transferrin (Tf) and degradation of basolater-
ally internalized epidermal growth factor (EGF; Barbieri et al., 2000; 
Wang et al., 2000b). In both cases, expression of TBC1D9B-WT (or 
TBC1D9B-RYQ/AAA) had no significant effect (Figure 8, C and D).
Finally, we rationalized that if TBC1D9B negatively regulates IgA 
transcytosis by its action on Rab11a, then depletion of TBC1D9B 
should increase the rate or extent of IgA transcytosis. TBC1D9B ex-
pression was knocked down in MDCK cells using specific shRNAs 
(shRNA-2), which decreased TBC1D9B expression by 88% (Figure 
8E). We observed a modest but significant increase in the kinetics of 
IgA transcytosis (Figure 8F). However, no significant effect was ob-
served if an inefficient shRNA (shRNA-1) was used, acting as a sec-
ond negative control. As expected, shRNA-mediated depletion of 
TBC1D9B had no effect on the Rab11a-independent pathways, ba-
solateral recycling of Tf, or degradation of basolaterally internalized 
EGF (Supplemental Figure S6, A and B). These results confirm a role 
of TBC1D9B in basolateral-to-apical transcytosis of IgA, a Rab11a-
dependent pathway.
Expression of TBC1D9B-WT reduces the amount of active 
Rab11a
The foregoing results are consistent with the possibility that TB-
C1D9B acts as a Rab11a GAP but do not directly address whether 
TBC1D9B affects the amount of active Rab11a in the cell. To exam-
ine this possibility more directly, we determined whether expression 
0.31 ± 0.04; Figure 6, B and E), which is consistent with previous 
observations that Rab11a is localized in part to this organelle (Ullrich 
et al., 1996; Chen et al., 1998). Small amounts of TBC1D9B colocal-
ized with the transferrin receptor (TfR; coefficient of colocalization of 
0.20 ± 0.05; Figure 6, B and F), which shows only modest colocaliza-
tion with Rab11a in MDCK cells (Brown et al., 2000; Leung et al., 
2000). However, as expected for a protein that interacts with Rab11a, 
a relatively large fraction of TBC1D9B was localized to Rab11a-pos-
itive vesicles (coefficient of colocalization of 0.48 ± 0.1; Figure 6, B 
and G.
We also measured the amount of colocalization between endog-
enous TBC1D9B and GFP-Rab11a, GFP-Rab11b, GFP-Rab25, or 
endogenous Rab4a and Rab8a (Supplemental Figure S4). Colocal-
ization was observed between TBC1D9B and most of the Rabs 
tested (Supplemental Figure S4D), but the amount of colocalization 
of TBC1D1B with Rab25 was low (coefficient of colocalization of 
∼0.1). It is prudent to note that Rab11b and Rab25 exhibit a moder-
ate to large degree of colocalization with Rab11a (Casanova et al., 
1999; Wang et al., 2000b; Lapierre et al., 2003; Butterworth et al., 
2012), and we observed that there was significant overlap between 
endogenous Rab11a with either Rab4a or Rab8a (coefficient of co-
localization of 0.49 ± 0.05 and 0.60 ± 0.05, respectively; unpub-
lished data). Unfortunately, we were unable to perform triple-label 
studies, as antibodies from additional species did not work in our 
hands or were not available.
Next, we determined whether TBC1D9B was localized to vesicle 
populations where Rab11a was likely to be in its active, GTP-bound 
state. One such vesicle pool is the apical recycling endosome, which 
is accessed by the pIgR late in its transit from the basolateral-to-
apical poles of the cell (Apodaca et al., 1994; Casanova et al., 1999; 
Wang et al., 2000a). As predicted, endogenous TBC1D9B colocal-
ized with Rab11a and the basolaterally internalized pIgR ligand, IgA, 
in subapical vesicles (coefficient of colocalization of 0.59 ± 0.02; 
Figure 7, A and D). In addition, TBC1D9B colocalized with vesicles 
positive for the pIgR (coefficient of colocalization of 0.54 ± 0.07; 
Figure 7, B and D) or the Rab11a (and Rab8a) effector, Sec15A, one 
subunit of the octameric exocyst complex (coefficient of colocaliza-
tion of 0.33 ± 0.04; Figure 7, C and D; Guo et al., 1999; Zhang et al., 
2004; Wu et al., 2005; Novick et al., 2006; Oztan et al., 2007).
We also determined whether TBC1D9B colocalized to a greater 
extent with the GFP-tagged Rab11aQ70L mutant. Indeed, we ob-
served higher degree of colocalization between endogenous TB-
C1D9B and GFP-tagged Rab11a-QL than with GFP-tagged Rab11a-
WT (coefficient of colocalization of 0.73 ± 0.03 and 0.61 ± 0.02, 
respectively; Figure 7, E–G). We also determined whether the local-
ization of Rab11a in MDCK cells was altered by expressing CFP-
TBC1D9B-WT or CFP-TBC1D9B-RYQ/AAA. However, we found no 
difference in the Rab11a distribution (Supplemental Figure S5, A 
and B; see Figure 9A later in this article), which is consistent with 
previous reports that the Rab11a-SN mutant remains membrane 
bound in MDCK cells (Wang et al., 2000b). There was also no change 
in Rab11a colocalization with these TBC1D9B variants (coefficient of 
colocalization of 0.72 ± 0.06 and 0.70 ± 0.06 for WT and RYQ/AAA, 
respectively; Supplemental Figure S5C). In contrast, in HEK cells, 
there was a significant redistribution of Rab11a from recycling endo-
capture GFP-Rab11aQ70L (QL) or GFP-Rab11aS25N (SN) from HEK cell lysates. Right, 2% of each lysate was resolved 
by SDS–PAGE and GFP-Rab11a detected by Western blot using anti-GFP antibody. Bottom left, GST constructs were 
resolved by SDS–PAGE and proteins detected using an anti-GST antibody. (G) Quantification of data from E and F. 
Values were normalized to total expression of the protein of interest and then to the values obtained for the GFP-
Rab11a-WT pull down. For A, B, and G, data are from at least three independent experiments, and the mean ± SEM is 
shown. Values significantly different from the group means, as assessed by ANOVA, are indicated (*p < 0.05).
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FIGURE 5: TBC1D9B interacts with Rab4a and Rab11b. (A) Left, coimmunoprecipitation of flag-tagged TBC1D9B with 
GFP-Rab11b-WT (11b-WT), GFP-Rab11b-Q70L (11b-QL), or GDP-locked GFP-Rab11bS25N (11b-SN) coexpressed in HEK 
cells. Anti-flag antibody was used to immunoprecipitate flag-TBC1D9B, and anti-GFP antibody was used to detect the 
coimmunoprecipitated GFP-tagged Rab protein. IgG was used as a nonspecific control. Right, 2% of each lysate was 
resolved by SDS–PAGE and overexpressed proteins detected by Western blot. Values were normalized to the total 
expression of each protein and then normalized to the amount of Rab11b-WT lysate. (B) Same as in A, but HEK cells 
coexpressed flag-TBC1D9B and GFP-Rab4a-WT (4a-WT), GFP-Rab4aQ72L (4a-QL), or GFP-Rab4aS27N (4a-SN). (C) Same as 
A, but the cells expressed Rab8aQ67L (8a-QL) or Rab11aQ70L (11a-QL), and after lysis, the incubations were performed in 
the absence of MgCl2. (D) Same as in A, but HEK cells coexpressed flag-TBC1D9B with GFP-Rab8a-WT (8a-WT), GFP-Rab8a-
Q67L (8a-QL), or GFP-Rab8a-T22N (8a-TN). (E–G) Top left, GST alone or GST-TBC1D9B-(301-810) (#2 fragment) was used to 
affinity capture GFP-Rab11a-QL and GFP-Rab11b-QL (E), GFP-Rab4a-QL (F). or GFP-Rab8a-QL (G). Right, 2% of each lysate 
was resolved by SDS–PAGE and GFP-Rab-QL detected by Western blot using anti-GFP antibody. Bottom left, GST 
constructs were resolved by SDS–PAGE and proteins detected on Western blots using an anti-GST antibody. 
(H) Quantification of data from E–G. Values are normalized to the total expression of the protein first and then to the values 
obtained for the GFP-Rab11a-WT pull down. Data were obtained from at least three independent experiments, and the 
mean ± SEM is shown. Values significantly different from the group means, as assessed by ANOVA, are indicated (*p < 0.05).
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of TBC1D9B-WT altered the amount of ac-
tive Rab11a in the cell and thereby affected 
its association with its effector Sec15A. As 
predicted, expression of TBC1D9B-WT de-
creased the amount of colocalization be-
tween Rab11a and Sec15A, whereas expres-
sion of TBC1D9B-RYQ/AAA was without 
effect (Figure 9, A and B). We also observed 
that the normally apically distributed Sec15A 
became more random in distribution when 
cells expressed TBC1D9B-WT but not when 
TBC1D9B-RYQ/AAA was expressed (Figure 
9A, middle). The total amount of Sec15A 
protein expressed in the cell was not af-
fected by expression of TBC1D9B-WT (Sup-
plemental Figure S7). However, a twofold 
increase in the expression of Sec15A was 
observed in cells expressing TBC1D9B-
RYQ/AAA (Supplemental Figure S7B).
We also sought to determine whether 
shRNA-mediated depletion of TBC1D9B 
would increase the amount of colocaliza-
tion between Rab11a and its effector, 
Sec15A, or whether it would affect the 
amount of Rab11a-GTP in the cell. How-
ever, depletion of TBC1D9B has no signifi-
cant effect on the amount of colocalization 
between Rab11a and Sec15A (Figure 9C). 
To measure the amount of Rab11-GTP in 
the cells, we used an effector-based pull-
down assay, using purified GST-tagged 
Sec15A to recover active Rab11a-GTP from 
cell extracts. We found no effect of decreas-
ing TBC1D9B expression on the amount of 
Rab11a-GTP (Figure 9, D and E). However, 
when TBC1D9B-RYQ/AAA was expressed, 
we observed a 2.5-fold increase in the 
nominal amount of Rab11a-GTP, as indi-
cated by increased interaction between 
Rab11a and Sec15A (Figure 9, E and F). In 
contrast, expression of TBC1D9B-WT re-
duced the amount of interaction between 
Rab11a and Sec15, likely by decreasing the 
amount of Rab11a-GTP in the cell (Figure 9, 
G and H).
In summary, overexpression of TBC1D9B 
decreases the amount of Rab11a-GTP in the 
cell and, in doing so, alters the interaction 
FIGURE 6: Subcellular localization of TBC1D9B in MDCK cells. Filter-grown MDCK cells were 
immunolabeled to show the distribution of the following endogenous proteins. (A) TBC1D9B 
and the tight junction–associated protein ZO-1 (xy-section, left), the apical membrane protein 
gp-135 (xz-section, top right), or actin (xz-section, bottom right). (B) Coefficient of 
colocalizations for endogenous TBC1D9B and the following markers: (C) TBC1D9B, actin, and 
EEA1 (an early endosome marker); (D) TBC1D9B, actin, and Lamp2 (a late endosome/lysosome 
marker); (E) TBC1D9B, actin, and giantin (a Golgi marker); (F) TBC1D9B, ZO-1, and TfR (a marker 
of the common recycling endosome and 
basolateral early endosomes); and  
(G) TBC1D9B, actin, and Rab11a (which is 
associated with the apical recycling 
endosomes in these cells). In A and C–G, 
single optical sections from the region just 
under the apical membrane (subapical), just 
above the nucleus (supranuclear), or at the 
level of the nucleus along the lateral 
membranes (medial) are shown. Boxed 
regions are magnified in the images below 
the word ZOOM. Scale bar, 5 μm. In B, data 
are mean ± SEM from three experiments 
(n > 100 cells).
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FIGURE 7: Localization of TBC1D9B at sites of active Rab11a function. (A) Filter-grown MDCK cells were pulse labeled 
with 200 μg/ml IgA at the basolateral surface for 20 min at 18°C and chased for 20 min at 37°C in the presence of apical 
Cy5-labeled anti-IgA antibodies. The cells were fixed and then immunolabeled to detect endogenous TBC1D9B (green), 
endogenous Rab11a (red), and transcytosed IgA (blue). In the merged panel, the boxed region is magnified in the 
bottom right inset. Magnified views of the individual channels are found in the insets under ZOOM. (B, C) MDCK cells 
were stained for endogenous TBC1D9B and either the (B) pIgR or (C) endogenous Sec15A. (D) Coefficient of 
colocalization for endogenous TBC1D9B and the indicated proteins. (E, F) MDCK cells were transfected with cDNA 
encoding GFP-Rab11a-WT (E) or GFP-Rab11a-QL (F) and after 72 h fixed and then stained for endogenous TBC1D9B. 
(G) Coefficient of colocalization for TBC1D9B and the indicated Rab11a construct. In (B, C, E, and F), the boxed region 
is magnified in the panels under the label ZOOM. Scale bar, 5 μm. In D and G, data were obtained from at least three 
independent experiments, and the means ± SEM are shown (n ≥ 150 cells). In G, a Student’s t test was used to show 
that difference between these two sample groups was significantly different (*p < 0.05).
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several biological screens (Itoh et al., 2006; 
Fuchs et al., 2007; Yoshimura et al., 2007; 
Ishibashi et al., 2009; Popovic et al., 2012), 
but there are no reports on whether it has 
GAP activity, nor is there information about 
its Rab substrates. In this work, we identified 
TBC1D9B as Rab GAP for vertebrate 
Rab11a. This conclusion derives from the 
following observations: 1) TBC1D9B is the 
closest homologue of the yeast protein 
Gyp2p, which is reported to be a GAP for 
the Rab11a homologue Ypt31p (Sciorra 
et al., 2005); 2) the TBC domain of TBC1D9B 
interacts with Rab11a and accelerates 
Rab11a GTPase activity in vitro, whereas the 
TBC1D9B-RYQ/AAA mutant is without ef-
fect; 3) endogenous TBC1D9B is found as-
sociated with Rab11a-positive compart-
ments; 4) in HEK cells, overexpression of 
TBC1D9B causes Rab11a to dissociate from 
recycling endosomes, apparently resulting 
in its redistribution to the cytosol; 5) in 
MDCK cells, overexpression of TBC1D9B 
impairs IgA transcytosis, a biological activity 
dependent on Rab11a, whereas down-reg-
ulation of TBC1D9B causes a modest but 
significant increase in IgA transcytosis; and 
6) overexpression of TBC1D9B decreases 
the apparent levels of the GTP-bound form 
of Rab11a in MDCK cells.
We calculated the catalytic efficiency of 
TBC1D9B toward Rab11a to be 158 M−1 s−1, 
which is modest compared with the cata-
lytic efficiencies reported for TBC1D1 (5.3 
× 103 M−1 s−1), TBC1D4 (2.8 × 103 M−1 s−1), 
and TBC1D20 (2.7 × 103 M−1 s−1; Sklan 
et al., 2007; Park et al., 2011) but compa-
rable to the activity of other TBC-domain 
containing proteins such as the Caenorhab-
ditis elegans homologue of TBC1D2, TBC-2 
(∼50 M−1 s−1; Chotard et al., 2010), and full-
length TBC1D20 (360 M−1 s−1; Sklan et al., 
2007). However, the value we calculated 
for TBC1D9B is likely to be an underesti-
mate, as we did not determine the catalytic 
efficiency of the full-length protein or un-
der different concentrations of Mg2+, which 
we showed affected TBC1D9B activity.
Although some GAPs are reported to 
have multiple Rab substrates (Du et al., 
1998; Nottingham et al., 2011; Frasa et al., 
2012; Lachmann et al., 2012), our experi-
ments indicate that TBC1D9B may be se-
lective for Rab11a. Indeed, we observed 
that TBC1D9B has only low levels of activity 
against a number of Rab GTPases, including Rab11b and Rab4a, 
both of which interacted with TBC1D9B in their GTP-locked states. 
We also observed that the TBC domain of TBC1D9B has activity 
against Rab8a; however, this was noted only when low concentra-
tions of Mg2+ were present in the assays. Thus, it is possible that 
under Mg2+-limiting conditions, Rab8a may serve as an additional 
substrate for TBC1D9B. We also observed that TBC1D9B was 
between Rab11a and Sec15A. In contrast, expression of TBC1D9B-
RYQ/AAA has the opposite effects.
DISCUSSION
Rab11a is a critical regulator of exocytosis, but there is a limited 
understanding of the proteins that regulate its GTPase cycle. Our 
studies focused on TBC1D9B, a protein that has been included in 
FIGURE 8: TBC1D9B regulates basolateral-to-apical transcytosis of IgA. The fraction of 
basolaterally internalized [125I]IgA that was transcytosed (A), the fraction of apically internalized 
[125I]IgA that was recycled (B), the fraction of basolaterally internalized [125I]Tf that was recycled 
(C), or the fraction of basolaterally internalized [125I]EGF that was degraded (D) was evaluated in 
filter-grown MDCK cells expressing CFP-TBC1D9B-WT or CFP-TBC1D9B-RYQ/AAA. (E) Top, 
RT-PCR analysis of MDCK cells expressing scrambled shRNA or specific shRNAs (shRNA1/2) that 
targeted canine TBC1D9B expression. Bottom, data are quantified. (F) Basolateral-to-apical 
transcytosis of [125I]IgA was measured in MDCK cells expressing either scrambled shRNA 
(shRNA Control) or shRNA-1/shRNA-2. In A–F, data were obtained from three independent 
experiments performed in triplicate, and the means ± SD are shown. Values different from the 
control, assessed by ANOVA, are indicated (*p < 0.05).
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FIGURE 9: TBC1D9B has GAP activity in cellula. (A) Localization of endogenous Rab11a and endogenous Sec15A in cells 
transduced with adenovirus encoding CFP-TBC1D9B-WT or the inactive mutant (-RYQ/AAA). Top, from the subapical 
region of the cell; bottom, xz-sections. (B, C) Coefficient of colocalization for the fraction of Rab11a that colocalizes with 
Sec15A (or vice versa) in MDCK cells transduced with adenovirus encoding CFP-TBC1D9B-WT or -RYQ/AAA (B) or in 
cells expressing shRNA-1 or shRNA-2 against canine TBC1D9B (C). In B, GFP expression was used as control, and in C, 
scrambled shRNA was used as control. (D) GST-Sec15A–mediated pull down of activated Rab11a in MDCK cells 
expressing scrambled shRNA (Control) or shRNA-2 specific for canine TBC1D9B. Left, immunoprecipitate from the 
pull down was analyzed by Western blot, using anti-GST and anti-Rab11a antibodies. Right, 2% of each lysate was 
analyzed by Western blotting, using anti-TBC1D9B and anti-Rab11a antibodies. (E) Data from D and F are quantified and 
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TBC1D9B-RYQ/AAA increases the nominal amount of Rab11a-GTP 
in the cell (measured by showing increased association between 
Rab11a and one of its effector proteins, Sec15A). These results are 
consistent with the possibility that this mutant acts in a dominant 
manner. However, this does not square with the lack of an obvious 
dominant effect on IgA transcytosis. One possibility is that TB-
C1D9B-RYQ/AAA stabilizes the Rab11a/Sec15A interaction, but 
any gains achieved in forming this interaction (likely at the level of 
tethering transcytotic vesicles) are offset by slowing the dissociation 
of Rab11a from Sec15A before vesicle fusion. Thus, it is possible 
that this mutant does have a dominant effect, but it was not re-
vealed by our experiments. One difference between TBC1D9B and 
other TBC GAPs studied is that a single R-to-A mutation commonly 
used in other studies (Will and Gallwitz, 2001; Haas et al., 2005; Itoh 
et al., 2006; Hannemann et al., 2012) is not enough to produce an 
inactive protein. This may indicate that other residues in or near the 
catalytic pocket of TBC1D9B can substitute or that the interaction 
between TBC1D9B and Rab11a is not adequately represented by 
the current structural models.
Although we identified TBC1D9B as a Rab11a GAP, there re-
mains much to understand about its physiological functions in the 
cell. Of great interest are previous reports that the pIgR is transcy-
tosed more efficiently when it binds IgA (Song et al., 1994), which 
stimulates activation of protein kinase C, release of inositol 1,4,5-tris-
phosphate, and increase in intracellular calcium (Cardone et al., 
1996). Of importance, TBC1D9B contains an EF hand, a well-de-
scribed Ca2+-binding motif in other proteins. Thus, one possibility is 
that Ca2+ binding to the EF hand may allosterically impair the func-
tion of TBC1D9B and in doing so increase the amount of active 
Rab11a and therefore extent of pIgR-IgA transcytosis. One possible 
way that Ca2+ may exert this influence would be by altering the func-
tion of the N-terminal GRAM domains, which by analogy to other 
proteins are likely to regulate the association of TBC1D9B with 
phospholipids (Doerks et al., 2000; Tsujita et al., 2004).
Finally, it has been proposed in the yeast secretory system that 
Gyp2p may be recruited by a Rab that acts downstream of Ypt31/32, 
possibly as an effector of Sec4p (or a similar GTPase), to regulate 
secretory vesicle maturation. By engaging Gyp2p, Sec4p would en-
sure compartmental identity by promoting the inactivation and dis-
sociation of Ypt31/32 from maturing vesicles (Sciorra et al., 2005). By 
analogy, we hypothesize that Rab4a and/or Rab11b could recruit 
TBC1D9B and in doing so generate endosomal microdomains/
compartments that are depleted of active Rab11a. In the case of 
Rab4, this would be a mechanism to sequester Rab4a cargoes, 
which undergo rapid recycling (Sonnichsen et al., 2000; Grant and 
Donaldson, 2009), from the relatively slow recycling pathways usu-
ally associated with Rab11a. Similarly, it could explain how the cell 
generates Rab11b-positive microdomains, which are critical for the 
recycling of cargoes distinct from those regulated by Rab11a 
(Lapierre et al., 2003; Silvis et al., 2009; Butterworth et al., 2012).
localized to Rab11a-containing endosomes and much less to 
EEA1-positive (and Rab5-positive) early endosomes or LAMP2-
positive late endosomes/lysosomes. Moreover, only Rab11a-de-
pendent endocytic pathways—for example, basolateral-to-apical 
transcytosis—were affected when TBC1D9B was overexpressed or 
when its endogenous protein levels were decreased by shRNA. 
Our results indicate that TBC1D9B is Rab11a specific at concentra-
tions of Mg2+ in the 2.5–5.0 mM range. However, additional experi-
ments may reveal that this protein targets other Rabs in other path-
ways, other cell types, or other physiological and developmental 
contexts.
In addition to TBC1D9B, there may be additional Rab11a GAPs, 
as is the case for other Rab GTPases (Fukuda, 2011; Frasa et al., 
2012; Chaineau et al., 2013). This could explain why depleting en-
dogenous TBC1D9B had only a modest effect on the rate of IgA 
transcytosis. In addition, the transcytotic pathway is also regulated 
by other Rabs (including Rab3b/d, Rab17, and Rab25; Hunziker and 
Peters, 1998; Zacchi et al., 1998; Larkin et al., 2000; Wang et al., 
2000b; van IJzendoorn et al., 2002), whose activities are unlikely to 
be affected by the loss of TBC1D9B expression. The presence of 
additional Rab11a GAPs could also explain why TBDC1D9B deple-
tion had no effect on the nominal levels of GTP-Rab11a in the cell 
(as assessed by binding to its Sec15A effector). Examples of poten-
tial Rab11a GAPs include Evi5, which has been described as a Rab-
11GAP in Drosophila melanogaster (Laflamme et al., 2012). How-
ever, whether Evi5 acts as a Rab11aGAP in mammalian cells is still 
controversial. For example, mammalian Evi5 interacts with Rab11a 
and can regulate Rab11a interaction with its effectors but apparently 
in a manner that is independent of its GAP activity (Westlake et al., 
2007; Hehnly et al., 2012). Of interest, TBC1D14 lacks GAP activity 
toward Rab11a but does interact with Rab11a in its GTP-bound 
state, indicating that it acts as an effector rather than a GAP for this 
GTPase (Longatti et al., 2012). Furthermore, TBC1D11/GAPCen, a 
Rab4 and Rab6 GAP, and TBC1D15, a Rab7 GAP, are reported to act 
as GAPs for Rab11a in vitro (Zhang et al., 2005; Fuchs et al., 2007). 
However, their activity has not been assessed in cellula. Finally, we 
note that TBC1D9B is a member of a subgroup named TBC-A (Gab-
ernet-Castello et al., 2013), which includes TBC1D8, TBC1D8B, 
TBC1D9, TBC1D9B, and Gyp2p. With the exception of TBC1D9B, 
which was studied here, the other mammalian TBC proteins in this 
subgroup are poorly characterized, and no substrates have been 
reported. However, it is possible that because of their high similarity, 
they could share similar substrates. In a similar manner, TBC1D10A 
and TBC1D10B were both identified as GAPs for Rab27A and, in a 
different study, as GAPs for Rab35 (Itoh and Fukuda, 2006; Hsu 
et al., 2010).
An interesting but perplexing finding is that TBC1D9B-RYQ/
AAA, like RA mutants in other TBC-containing proteins (Will and 
Gallwitz, 2001; Haas et al., 2005), shows increased interaction with 
its cognate Rab. Moreover, we observed that expression of 
normalized to control incubations. (F) GST-Sec15A pull down of activated Rab11a in MDCK cells expressing CFP-
TBC1D9B-RYQ/AAA (+RYQ) compared with control cells expressing endogenous TBC1D9B (–). Left, the precipitate from 
the pull down was analyzed by Western blot, using anti-GST and anti-Rab11a antibodies. Right, 2% of each lysate was 
analyzed by Western blot, using anti-GFP and anti-Rab11a antibodies. (G) GST-Sec15A pull down of activated Rab11a in 
MDCK cells expressing CFP-TBC1D9B-WT (+WT) or -RYQ/AAA (+RYQ). CFP-TBC1D9B-WT and -RYQ/AAA were 
detected using anti-GFP antibody, endogenous Rab11a was detected using anti-Rab11a antibody, and GST-Sec15A was 
detected using GST antibody. (H) Data from G are quantified. In B, C, E, and H, data were obtained from at least three 
independent experiments, and mean ± SEM is shown. Values different from the control, assessed by ANOVA, are 
indicated (*p < 0.05).
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Immunoprecipitation
Immunoprecipitations were performed as described previously with 
minor modifications (Oztan et al., 2007). Briefly, HEK cells were 
cotransfected, as described, with flag-tagged TBC1D9B and GFP-
tagged Rab constructs. The GFP-tagged Rab constructs with Q-to-L 
mutation in their switch II active region, used for the Rab screen 
(Figure 2A), were described previously (Azouz et al., 2012). After 
24–48 h transfection, HEK cells were washed with ice-cold phos-
phate-buffered saline (PBS), gently scraped into cold PBS using a 
flexible cell scraper, and then recovered by centrifugation at 1500 × 
g. The cells were resuspended in IP buffer (10 mM Tris, pH 7.4, 
150 mM NaCl, 2.5 mM MgCl2, 5 mM EDTA, 10% glycerol, 1% NP-
40, 1 mM phenylmethylsulfonyl fluoride [PMSF], and 5 μg/ml each 
of pepstatin, leupeptin, and antipain), and after incubation for 
30 min on ice, the cells were passed 20 times through a 25-gauge 
syringe and the lysate centrifuged 10 min at maximum speed in a 
5424R microcentrifuge at 4°C (Eppendorf, Westbury, NY). The su-
pernatants were transferred into a new tube and then incubated 
overnight at 4°C on a rotator with 1 μg of anti-flag M2 antibody 
or 1 μg of nonspecific mouse IgG as a control. Next, 30 μl of a 
50% (vol/vol) slurry of Protein G Sepharose 4FastFlow beads (GE 
Healthcare) was added to each tube, and the reaction was incu-
bated at 4°C for 1 h on a rotator. Tubes were centrifuged for 1 min 
at 2000 × g, and the beads were washed five times with IP buffer 
and then resuspended in 25 μl of 2× Laemmli sample buffer. When 
the Rab screen was performed (Figure 2A), the washes were made 
using the IP buffer supplemented with 300 mM NaCl. When stated 
in the text, MgCl2 was omitted from the IP buffer. The samples were 
heated at 70°C for 10 min, the cell lysate was resolved by SDS–
PAGE, and Western blots, performed as described previously 
(Oztan et al., 2007), were probed with the indicated primary anti-
bodies. To quantify the binding efficiency of the coimmunoprecipi-
tating proteins, the bands detected in the immunoblots were quan-
tified using ImageJ software (National Institutes of Health, Bethesda, 
MD). Values were normalized to total expression of each protein.
Yeast two-hybrid assay
For yeast two-hybrid experiments the MATCHMAKER GAL4 Two-
Hybrid System (Clontech Laboratories, Mountain View, CA) was 
used. TBC1D9B-WT or TBC1D9B-RA were cloned into pLexA vec-
tor. Human Rab4, Rab5, Rab6, Rab7, Rab11a, and Rab33 were 
cloned into pB42AD vector. Experiments were performed according 
to the directions supplied by the manufacturer.
Purification of GST-fusion proteins
cDNAs encoding full-length mammalian Rab GTPases fused to GST 
were described previously (Pan et al., 2006) and kindly provided by 
D. G. Lambright (University of Massachusetts, Worcester, MA). GST-
Rab11b was subcloned from GFP-hRab11b (kindly provided by 
Robert Edinger, University of Pittsburgh, Pittsburgh, PA) into the 
pGEX4T1 vector. TBC1D9B fragments (residues 450–950, 450–810, 
301–810, 1–450, and 810–1250) were subcloned into the pGEX4T1 
vector. Plasmids encoding the Rabs or TCB1D9B fragments were 
introduced into BL21-CodonPlus (DE3)-RIPL E. coli cells (Agilent 
Technologies, Santa Clara, CA) by transformation and expression 
induced with 0.5 mM isopropyl-β-d-thiogalactoside for 16 h at 30°C. 
Cells were collected by centrifugation at 8000 × g and the cell pellet 
dissolved in lysis buffer (20 mM 4-(2-hydroxyethyl)-1-pipera-
zineethanesulfonic acid [HEPES], pH 8, 500 mM NaCl, 0.5% [vol/vol] 
Triton X-100, 5 mM MgCl2, 1 mM dithiothreitol [DTT], 1 mM PMSF, 
and 5 μg/ml each of pepstatin, leupeptin, and antipain). When puri-
fying the Rabs, 200 μM GDP was included in the lysis buffer. DNA 
MATERIALS AND METHODS
Antibodies and reagents
All reagents were obtained from Sigma-Aldrich (St. Louis, MO) un-
less otherwise stated. Rhodamine-phalloidin and TO-PRO-3 were 
obtained from Molecular Probes-Invitrogen/Life Sciences (Grand Is-
land, NY). Antibodies used were as follows: mouse anti-flag M2 and 
rabbit anti-GFP (Abcam, Cambridge, MA), mouse anti-Rab11a 
(8H10) and rabbit anti-Rab11a (Goldenring et al., 1996; Lapierre 
et al., 2003), goat anti-GST (GE Healthcare, Pittsburgh, PA), rat anti-
ZO1 hybridoma R40.76 culture supernatant (D. A. Goodenough, 
Harvard University, Cambridge, MA), mouse anti-gp135 hybridoma 
3F2/D8 (G. Ojakian, State University of New York, New York, NY), 
mouse anti-EEA1 (BD Biosciences, San Jose, CA), mouse anti–
LAMP-2 antibody AC17 (E. Rodriguez-Boulan, Cornell University, 
New York, NY), mouse anti-giantin (Adam Linstedt, Carnegie Mellon 
University, Pittsburgh, PA), mouse anti-Tf receptor antibody H68.4 
(Invitrogen, Carlsbad, CA), goat anti-Rab4a (Santa Cruz Biotech-
nology, Dallas, TX), mouse anti-Rab8a (BD Biosciences), human 
polymeric IgA (purchased from J. P. Vaerman, Catholic University of 
Louvain, Louvain, Belgium), mouse anti-pIgR antibody SC166 (Solari 
et al., 1985), goat anti-Sec15A (Santa Cruz Biotechnology), and goat 
anti–glyceraldehyde-3-phosphate dehydrogenase (Proteintech, 
Chicago). Horseradish peroxidase–, CY5-, and Dylight 488–, 549–, 
and 649–conjugated, affinity-purified, and minimal cross-reacting 
secondary antibodies were from Jackson ImmunoResearch Labora-
tories (West Grove, PA).
Cloning of TBC1D9B and sequence analysis
For mammalian expression, full-length human TBC1D9B (Accession 
Number NP_942568.2) was obtained from Open Biosystems 
(Thermo Fisher Scientific, Waltham, MA). The cDNA was amplified 
by PCR and cloned into pEGFP-C1 vector for GFP tagging or 
pCDN3.1+ for flag tagging. The inactive mutant was produced by 
mutagenesis using the QuikChange Multi Site-Directed Mutagene-
sis Kit (Agilent Technologies, Santa Clara, CA), and the following 
residues were mutated: R559 to A, Y592 to A, and Q594 to A. Se-
quence alignments were performed using National Center for Bio-
technology Information’s BLASTp, and the Clustal format was pro-
duced with MAFFT software (Larkin et al., 2007; Katoh and Standley, 
2013). Structure prediction and comparison was performed using 
Geneo3D (http://geno3d-pbil.ibcp.fr), with TBC1D4 (PDB 3QYB) as 
a template. Images were produced and structures were aligned with 
PyMol (DeLano, 2002).
Cell culture and transfection
HeLa and HEK 293FT (HEK; Invitrogen) cells were grown in DMEM 
(Cellgro, Herndon, VA) supplemented with 10% fetal bovine serum 
(FBS; Hyclone, Logan, UT) and 1% penicillin/streptomycin in a 37°C 
incubator gassed with 5% CO2. For transient transfection, these 
cells were plated on coverslips or on 10-cm tissue culture plates ac-
cording to the experiment requirements, and after 24 h they were 
transfected with DNA using Lipofectamine 2000 according to the 
manufacturer’s instructions (Invitrogen).
MDCK type II cells expressing the wild-type rabbit pIgR (pWe) 
have been described (Breitfeld et al., 1989). Cells were grown in 
MEM (Cellgro, Herndon, VA) containing 10% (vol/vol) FBS (Hyclone) 
and 1% penicillin/streptomycin (pen/strep) in a 37°C incubator 
gassed with 5% CO2. Cells were cultured on 0.4-μm and 12-mm 
Transwells (Costar, Cambridge, MA) and used 3–4 d after culture as 
described (Breitfeld et al., 1989). Cells were transfected in suspen-
sion as described previously (Mo et al., 2010), using the appropriate 
vector and Lipofectamine 2000 reagent.
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using the BCA Kit (Promega, Madison, MI). One milligram of total 
protein was incubated with 0.5 μg of anti-flag antibody prebound to 
Protein G Sepharose 4 FastFlow beads for 2 h at 4°C with end-to-
end rotation. The flag-TBC1D9B-beads were washed three times 
with lysis buffer, four times with PBS, and two times with assay buffer. 
An aliquot was kept to confirm the efficiency of the immunoprecipi-
tation, and the remaining beads containing bound GAP were di-
rectly added to the described GAP assay. Untransfected HeLa cells 
were lysed, treated as described, and used as a control in the GAP 
assay.
Detection of interactions between TBC1D9B fusion proteins 
and Rab GTPases
HEK cells were transfected with cDNA encoding GFP-Rab con-
structs (either wild-type or mutant forms) and lysed 24–48 h post-
transduction in IP buffer containing 1 mM GTP. The cell lysate was 
centrifuged and the supernatant “precleared” by incubating the 
lysate with GSH Sepharose-4B beads (GE Healthcare) for 30 min at 
4°C. After a brief centrifugation at 2000 × g, an aliquot of lysate 
containing 250 μg of total protein was mixed with 1 μg of purified 
TBC1D9B fusion protein and interacting complexes recovered by 
the addition of 25 μl of GSH beads and incubation for 3 h at 4°C 
on a rotator. The reactions were centrifuged for 1 min at 2000 × g, 
and the beads were washed five times with IP lysis buffer. The 
beads were resuspended in 25 μl of 2× Laemmli sample buffer, 
heated at 70°C for 10 min, the proteins resolved by SDS–PAGE, 
and Western blots probed with the indicated primary antibodies. 
When stated in the text, no MgCl2 was added to the IP buffer. To 
quantify the binding efficiency in the pull-down experiments, we 
quantified the bands detected in the immunoblots using ImageJ 
software. Values were normalized to total expression of each pro-
tein in the lysate and the corresponding amount of GST protein 
used in each experiment.
Immunofluorescence and colocalization analysis
For immunofluorescence studies, MDCK cells were washed in PIPES-
KOH buffer (80 mM 1,4-piperazinediethanesulfonic acid [PIPES]–
KOH, pH 6.8, containing 2 mM MgCl2 and 5 mM ethylene glycol 
tetraacetic acid) and then fixed for 5 min with 4% (wt/vol) paraform-
aldehyde (Electron Microscopy Sciences, Hatfield, PA) dissolved in 
PIPES-KOH buffer (adjusted to pH 6.5 by the addition of HCl), fol-
lowed by 10 min in 4% (wt/vol) paraformaldehyde dissolved in 100 
mM sodium borate buffer (pH 11.0; Bacallao and Stelzer, 1989; 
Apodaca et al., 1994). After fixation, unreacted paraformaldehyde 
was quenched for 10 min at room temperature with PBS containing 
20 mM glycine, pH 8.0, and 75 mM NH4Cl, with the addition of 
0.1% Triton X-100. Fixed cells were incubated with block buffer 
(0.025% [wt/vol] saponin and 8.5 mg/ml fish-skin gelatin dissolved in 
PBS) for 60 min at room temperature. Cells were incubated with 
primary antibody, diluted in block buffer for 1 h at room tempera-
ture or 16 h at 4°C, washed three times with block buffer for 5 min, 
and then incubated with fluorescence-labeled secondary antibodies 
(diluted in block buffer) for 1 h at room temperature. After three ad-
ditional 5-min washes with block buffer, the cells were rinsed with 
PBS, fixed with 4% (wt/vol) paraformaldehyde in 100 mM sodium 
cacodylate, pH 7.4, for 10 min at room temperature, and then 
mounted as described previously (Apodaca et al., 1994).
To label transcytosing IgA, filter-grown MDCK cells were washed 
with MEM/bovine serum albumin (BSA; MEM containing 0.45 g/ml 
NaHCO3, 0.6% [wt/vol] BSA, 10 mM HEPES, pH 7.4, and pen/strep/
Fungizone) and incubated at 18°C for 15 min. IgA, 200 μg/ml, was 
internalized from the basolateral surface of the cells for 20 min at 
was sheared by treating the lysates with 10 sonic pulses (15-s dura-
tion each) using a Model 100 Sonic Dismembrator (Fisher Scientific). 
After centrifugation for 30 min at 4°C at 15,000 × g, the superna-
tants were recovered and subsequently incubated with reduced glu-
tathione (GSH) Sepharose-4B beads (GE Healthcare) for 3 h at 4°C 
with rotation. The proteins bound to the beads were then recovered 
by centrifugation at 5000 × g, washed four times with lysis buffer, 
and GST-fusion proteins released from the beads by incubating 
them with elution buffer (10 mM GSH in 100 mM Tris, pH 8, contain-
ing 1 mM DTT). Proteins were concentrated fourfold and equili-
brated in dialysis buffer (10 mM Tris, pH 7.5, 0.1 mM DTT, 2 mM 
MgCl2, 150 mM NaCl) using Amicon-Ultra-4 centrifugal filters (EMD 
Millipore, Billerica, MA). Quantification of proteins was performed 
using the bicinchoninic acid assay (BCA) Kit (Promega, Madison, 
WI). Glycerol was added to a final concentration of 10% (vol/vol) and 
the purified proteins were divided into aliquots, snap-frozen using 
liquid nitrogen, and then stored at −80°C.
In vitro GAP assay
The efficiency of GTP binding to purified Rabs and GAP assays were 
performed as described previously (Haas et al., 2005; Fuchs et al., 
2007; Yoshimura et al., 2008). To estimate the former, 100 pmol of 
GST-Rab protein was mixed on ice with 100 μl of assay buffer (50 
mM HEPES-NaOH, pH 6.8, 1 mM DTT, 0.2 mg/ml bovine serum al-
bumin, 1 mM EDTA, pH 8.0, and 0.5 mM of an equal mixture of GTP 
and MgCl2) containing 2 μl of [γ-32P]GTP (10 mCi/ml; 4500 Ci/mmol; 
MP Biomedicals, Solon, OH), and the reaction was then incubated 
for 15 min at 30°C. The efficiency of binding was evaluated by nitro-
cellulose-filter assay (Kabcenell et al., 1990). For GAP assays, the 
indicated concentration and fragment of TBC1D9B was added to 
this reaction mixture and then incubated at 30°C for up to 60 min. In 
some experiments, 5 mM MgCl2 was added in the GAP reaction as 
described previously (Du et al., 1998; Albert et al., 1999; Notting-
ham et al., 2011; Lachmann et al., 2012). A 2-μl aliquot of the reac-
tion was counted directly to measure the specific activity in cpm/
picomole GTP. The 32Pi release was quantified by taking duplicate 
2-μl samples from the GAP reaction and mixing them with 795 ml of 
ice-cold activated charcoal (5% vol/vol in 50 mM NaH2PO4), which 
specifically binds to Pi. The charcoal was recovered by centrifuga-
tion at 10,000 × g, and the radioactivity within a 400-μl aliquot of the 
cleared supernatant was measured by Cerenkov counting in a Wal-
lac 1409 liquid scintillation counter (PerkinElmer, Waltham, MA). The 
amount of hydrolyzed GTP (32Pi release) was calculated from the 
specific activity of the reaction mixture (Yoshimura et al., 2008) and 
normalized to the fraction of GTP-bound Rab, which was measured 
as described using the nitrocellulose-binding assay (Kabcenell et al., 
1990). Where indicated, data were fitted to a pseudo-first-order 
Michaelis–Menten model in which y(t) = Amax[1 − exp(−Kobst)], where 
Amax corresponds to the maximum amount of hydrolyzed GTP and 
Kobs is the observed rate constant for the GTP hydrolysis. For each 
tested concentration of TBC1D9B-(301-810), a Kobs value was ob-
tained, and the catalytic efficiency (Kcat/Km) relative to the intrinsic 
rate constant of GTP hydrolysis (Kintr) was calculated from the linear 
dependence between Kobs and the evaluated GAP concentrations, 
Kobs = Kintr + (Kcat/Km)[GAP] (Pan et al., 2006). Initial velocities (Vi) 
were calculated as Vi = AmaxKobs, where Amax and Kobs were ob-
tained from the described fitted pseudo-first-order curves.
A previously described procedure was used to measure the GAP 
activity of full-length TBC1D9B (Nottingham et al., 2011). Briefly, 
HeLa cells were transfected with either flag-TBC1D9B-WT or flag-
TBC1D9B-RYQ/AAA, and 24 h later, the cells were solubilized in lysis 
buffer as described and the total amount of protein was quantified 
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18°C. The cells were then incubated for 20 min at 37°C, during 
which 25 μg/ml Cy5-labeled anti–human IgA was added to the 
apical media. The cells were then washed with ice-cold MEM/BSA 
and then PBS and finally fixed with 4% (wt/vol) paraformaldehyde in 
100 mM sodium cacodylate, pH 7.4, for 10 min at room tempera-
ture (Oztan et al., 2007). Unreacted paraformaldehyde was 
quenched, and the cells were labeled as described.
Images were captured using an HCX PL APO 100×/numerical 
aperture (NA) 1.4 oil objective (Leica, Wetzlar, Germany) and the 
appropriate laser lines of a Leica TCS SP5 CW-STED confocal micro-
scope (in normal confocal mode). The photomultipliers were set at 
800–1000 V and zoom at 4×, and 8-bit images were collected using 
four to eight line averages combined with four to eight frame aver-
ages. Serial 0.25-μm z-sections were acquired. The images (512 × 
512 pixels) were imported into Volocity 3D software (PerkinElmer, 
Waltham, MA) and, after image reconstruction, exported as TIFF 
files. The contrast of the latter was corrected in Photoshop CS5 
(Adobe, San Jose, CA), and the composite images were prepared in 
Adobe Illustrator CS5.
Measures of colocalization were performed as described previ-
ously (Khandelwal et al., 2008; Khandelwal et al., 2013). Briefly, 
stacks of dual-labeled confocal sections were imported into Voloc-
ity software, background noise was removed using the fine (3 × 3) 
median noise reduction filter, and a scatter plot of voxel intensities 
for each of the markers was generated using the colocalization 
function. The images were thresholded using a fixed value of 40, 
and Mx, the Manders colocalization coefficient, was calculated for 
the entire 3D volume. An Mx value of 1.0 indicates that the ratio 
for all x intensity values that have a corresponding y intensity (i.e., 
are colocalized) divided by the sum of all x intensity values is 
100%. In contrast, a value of 0.0 indicates that there is no 
colocalization.
Antibody production for anti-TBC1D9B in rabbits
The anti-TBC1D9B antibody is a rabbit polyclonal antibody made 
by Cocalico Biologicals (Reamstown, PA), using a KLH-conjugated 
peptide EEDEPPAPELHQDAARELQ (amino acids 1082–1100) from 
the human TBC1D9B isoform (NP_942568.2). The antibody produc-
tion was approved by the University of Pittsburgh Institutional Ani-
mal Care and Use Committee, Protocol 0809099-1. This antibody 
was used in immunoblots and immunofluorescence studies.
Adenovirus production and transduction
Full-length TBC1D9B-WT and -RYQ-AAA were cloned into the 
pECFP vector (Clontech Laboratories ) and subcloned into pAdLOX 
vector (Hardy et al., 1997). These constructs were transfected into 
Cre8 cells, and the adenovirus was produced and amplified as previ-
ously described (Henkel et al., 1998; Khandelwal et al., 2008). Other 
constructs used were previously described: GFP/HA-Rab11a-WT, 
GFP/HA-Rab11a-S25N, GFP-Rab25 (Khandelwal et al., 2008), and 
GFP-Rab8a-T22N (Khandelwal et al., 2013). Adenovirus was trans-
duced into MDCK cells as described previously (Henkel et al., 1998; 
Oztan et al., 2007). Adenoviral-mediated expression of CFP-TB-
C1D9B was detected by immunofluorescence using anti-GFP 
staining.
Lentivirus shRNA production and transduction
To decrease the expression of canine TBC1D9B, shRNA sequences 
were generated using an (AA)N19 algorithm and iRNAi software 
(www.mekentosj.com). The target sequences were (5′–3′): shRNA-1, 
GACGACATGTCCATGTCCT; shRNA-2, GGTGGAGAGACAGT-
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TCAGC; and scrambled, CCGCAGGTATGCACGCGT. The se-
quences were cloned into the pLKO.1 vector (Addgene) and lentivi-
ruses produced in 293FT cells using the ViraPower packaging kit 
(Invitrogen) according to the manufacturer’s instructions. Infection of 
the MDCK cells was performed as described previously (Bryant 
et al., 2010), and cells expressing the shRNA were enriched by incu-
bating the transduced cells in medium containing 5 μg/ml puromy-
cin. The expression of endogenous TBC1D9B was detected by re-
verse transcription (RT)-PCR using the RETROscript First Strand 
Synthesis Kit (Life Technologies), followed by PCR using Taq poly-
merase (Life Techno logies). PCR primers, designed using the pre-
dicted sequences of canine TBC1D9B (XM_538581.4), were as fol-
lows (5′–3′): forward primer, GCAGGACGCATGTTCCGGCT, and 
reverse primer, CACCGTGGCGATGGCATGGT. Actin was used as 
control. Sequencing was used to confirm the identity of the PCR 
products. To quantify the effectiveness of the shRNAs, PCR reaction 
products were separated on agarose gels, photographed using a 
Gel Doc XR+ Imaging System (Bio-Rad, Hercules, CA), and then 
quantified using ImageJ software. Values were normalized to actin 
expression. To deplete cells of Rab11a, shRNA specific for canine 
Rab11a was described previously (Bryant et al., 2010) and kindly 
provided by D. M. Bryant (University of California, San Francisco, 
San Francisco, CA).
125I-IgA transcytosis, 125I-IgA apical recycling, 
125I-Tf recycling, and 125I-EGFR degradation
The postendocytotic fates of 125I-IgA, 125I-Tf and 125I-EGF were de-
termined as described previously (Apodaca et al., 1994; Maples 
et al., 1997; Leung et al., 1999; Oztan et al., 2007).
Effector-based, pull-down assay to measure activated 
Rab11a
For this assay, a GST-ratSec15A full-length construct was used to 
produce recombinant protein as described previously (Oztan et al., 
2007). MDCK cells were transduced with CFP-TBC1D9B-WT or 
-RYQ/AAA adenovirus as described. After 48 h, the cells were 
solubilized in IP buffer as described, and the lysate was incubated 
with 1 μg GST-Sec15A for 2 h at room temperature with rotation. 
GSH Sepharose-4B beads were used to pull down GST-Sec15A and 
the endogenous GTP-bound Rab11a associated with Sec15A. The 
beads were washed four times with lysis buffer and resuspended in 
2× Laemmli sample buffer. The samples were heated at 95°C for 
2 min and resolved by SDS–PAGE, and Rab11a was detected by 
Western blot. A similar protocol was used with MDCK cells trans-
duced with lentivirus expressing scrambled shRNA or shRNA-2 tar-
geting canine TBC1D9B.
Statistical analysis
Data are reported as mean ± SEM. Statistically significant differences 
between means were determined using a two-tailed Student’s t test; 
p < 0.05 was considered statistically significant. One-way analysis of 
variance (ANOVA), with Bonferonni’s correction, was used when 
making multiple comparisons.
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